The ethical case for providing cost-free access to lifesaving HIV medications in Canada: Implications of a qualitative study.
Healthc Manage Forum
; 29(6): 255-259, 2016 Nov.
Article
in En
| MEDLINE
| ID: mdl-27744277
ABSTRACT
Antiretroviral therapy for HIV can be expensive if paid for out of pocket. In Canada, there are a variety of federal, provincial, and private prescription drug plans that lower the cost of these lifesaving medications for people living with HIV, and in some cases, these plans result in cost-free access. However, many people living with HIV must contend with high deductibles for their antiretroviral therapies, and many experience difficulty managing the administrative requirements of their drug plans. This article comments on some of the results of a qualitative study into ethical issues in HIV care. Access to antiretrovirals was a theme that emerged in this study. We argue on ethical grounds that provincial drug plans should guarantee cost-free access to antiretroviral therapies for people living with HIV with minimal administrative requirements.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Anti-HIV Agents
/
Deductibles and Coinsurance
Type of study:
Health_economic_evaluation
/
Qualitative_research
Aspects:
Ethics
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Healthc Manage Forum
Journal subject:
HOSPITAIS
/
SERVICOS DE SAUDE
Year:
2016
Document type:
Article
Affiliation country:
Canada
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA